VivoSeq
Other

Esketamine

0

Pipeline Programs↗

8

Active Trials↗

2

Companies Involved↗

Esketamine is an early-stage landscape with 0 programs across 2 companies. The most active players are Johnson & Johnson, Celon Pharma SA.

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

91/100

Attrition Rate

5/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Johnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalC

Celon Pharma SA

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

42

clinical trials

Completed20 · 48%
Unknown status12 · 29%
Recruiting7 · 17%
Withdrawn2 · 5%
Not yet recruiting1 · 2%

Clinical Trials

Trial Activity

42 trials

Ayahuasca, Esketamine and Premenstrual Symptoms
Recruiting·UUniversity of Sao Paulo·N/A·NCT07317232·20 enrolled
Effect of Esketamine on Conscious State in Patients With pDoC
Recruiting·—·N/A·NCT06389344·116 enrolled
Immunoinflammatory Regulation of Esketamine in Septic Patients
Recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 4·NCT04843982·100 enrolled
IV Ketamine Vs. in Esketamine for MDD TRD
Recruiting·—·N/A·NCT06488586·80 enrolled
Ayahuasca, Esketamine and Body Image Perception
Recruiting·UUniversity of Sao Paulo·N/A·NCT07317219·20 enrolled
Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial
Recruiting·—·Phase 3·NCT06051227·608 enrolled
Ayahuasca, Esketamine and PTSD
Recruiting·UUniversity of Sao Paulo·Phase 2·NCT07317206·10 enrolled
Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain
Not yet recruiting·—·N/A·NCT06914206·184 enrolled
A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Volunteers
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 1·NCT01980303·29 enrolled
Pharmacokinetic Study of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy Participants
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 1·NCT02568176·71 enrolled
(GluEsk) Glutamate and Esketamine
Completed·UUniversity of Oxford·N/A·NCT06432322·16 enrolled
Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine
Completed·UUniversity Hospital, Basel, Switzerland·Phase 1·NCT00847418
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 1·NCT01780259·58 enrolled
Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 1·NCT02846519·66 enrolled
A Study to Evaluate the Pharmacokinetics of Intranasal Esketamine Administered With and Without a Nasal Guide on the Intranasal Device
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 1·NCT02060929·14 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)